Slimpro® is derived from the Northern Blue Whiting fish caught by Compagnie des Peches, off the banks of Newfoundland. It is the only fish peptide on the market that acts naturally by enhancing the digestion process, specifically targeting the gut hormones CCK and GLP1. It is fortified with BCAA's which means it has a complete amino acid profile.
Targets:
Weight Control - New Moms - Stop Snacking - Recent non-smokers
*in-vivo, in-vitro and a pre-clinical has been performed with a full double-blind clinical trial underway.
A study was performed on the STC-1 cell line, derived from the small intestine of mice. A very low dose of Slimpro® was incubated and had amplified the hormone signal (satiating effect) increasing CCK and GLP-1 secretion.
In another study performed for a two week period, rats were given a preload orogastric administration(tube feeding) dose containing Slimpro® and the placebo group was given water. Results showed a diminution of food intake with dose-effect and were correlated to an increase of the CCK and GLP-1 plasma levels. Moreover, there was a light decrease in the body weight gain.
In the pre-clinical, 15 overweight women were selected to perform a two week pilot study consuming 1 gram of SlimPro® encapsulated, twice daily. According to the Visual Analogue Scale, they reported their sensations of fullness. Afterwards, they tested the kinetic effect of SlimPro® after a standard breakfast on food intake. There was a significant difference between the Slimpro® group and Placebo group concerning sweet hunger and glycemia.
Reader Comments